Journal of Neurology

, Volume 255, Issue 10, pp 1596–1596 | Cite as

Heart valve abnormalities in Parkinson’s disease treated with dopamine agonists

  • M. Bareš
  • I. Rektorová
  • L. Krajčovičová
  • I. Rektor
LETTER TO THE EDITORS

References

  1. 1.
    Dewey RB, Reimold SC, O’Suilleabhain PE (2007) Cardiac valve regurgitation with pergolide compared with non- ergot agonists in Parkinson’s disease. Arch Neurol 64:377–380PubMedCrossRefGoogle Scholar
  2. 2.
    Línková H, Růžička E, Pěnička M (2007) Dopamine agonists and valvular heart disease-letter to the editor. N Engl J Med 356:16CrossRefGoogle Scholar
  3. 3.
    Růžička E, Línková H, Pěnička M, Ulmanová O, Nováková L, Roth J (2007) Low incidence of restrictive valvulopathy in patients with Parkinson’s disease on moderate dose of pergolide. J Neurol 254(11):1575–1578PubMedCrossRefGoogle Scholar
  4. 4.
    Simonis G, Fuhrmann JT, Strasser RH (2007) Meta-analysis of heart valve abnormalities in Parkinson’s disease patients treated with dopamine agonists. Mov Disord 22(13):1936–1942PubMedCrossRefGoogle Scholar
  5. 5.
    Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007) Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 356:39–46PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • M. Bareš
    • 1
  • I. Rektorová
    • 1
  • L. Krajčovičová
    • 1
  • I. Rektor
    • 1
  1. 1.Brno Movement Disorders Center and 1st Dept. of NeurologyMasaryk University, St. Anne’s HospitalBrnoThe Czech Republic

Personalised recommendations